Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBPC: Carboplatin-Etoposide vs Topotecan in Relapsed SCLC
NCT02738346Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Jul 2013
- Primary completion
- Jul 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, etoposide in small cell lung cancer (SCLC), sponsored by Centre Hospitalier Universitaire d'Angers. Status: unknown.
02
Drugs
carboplatinetoposide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT02738346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02738346.